FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: IMPROVING ANAPHYLAXIS OUTCOMES: APPROACHES FOR ENHANCING ACCESS TO EPINEPHRINE; PUBLIC WORKSHOP; REQUEST FOR COMMENTS

WASHINGTON, Nov. 24 -- Food and Drug Administration has issued a notice called: Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments.

The notice was published in the Federal Register on Nov. 24 by Lowell M. Zeta, Acting, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine." The purpose of the public workshop is to initiate a discussion on expanding epinephrine accessibility and use, including in community settings, to reduce anaphylaxis-related morbidity and ...